|
RAB3GAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.004200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.737700E-03 |
| Normal-vs-Stage2 |
5.376100E-02 |
| Normal-vs-Stage3 |
1.033690E-04 |
| Normal-vs-Stage4 |
5.353500E-04 |
| Stage1-vs-Stage2 |
7.692200E-01 |
| Stage1-vs-Stage3 |
1.256970E-01 |
| Stage1-vs-Stage4 |
2.669600E-01 |
| Stage2-vs-Stage3 |
1.970020E-01 |
| Stage2-vs-Stage4 |
2.802600E-01 |
| Stage3-vs-Stage4 |
9.576600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.018110E-04 |
| Normal-vs-AfricanAmerican |
1.781230E-01 |
| Normal-vs-Asian |
4.575900E-02 |
| Caucasian-vs-AfricanAmerican |
2.118400E-01 |
| Caucasian-vs-Asian |
2.386200E-01 |
| AfricanAmerican-vs-Asian |
7.578000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.809860E-04 |
| Normal-vs-Female |
2.319600E-03 |
| Male-vs-Female |
1.702180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.917500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.575900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.197620E-04 |
| Normal-vs-Age(81-100Yrs) |
2.925900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.531400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.916590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.805600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.661400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.167200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.031400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.558600E-01 |
| Classical-VS-Follicular |
2.317800E-01 |
| Classical-VS-Other |
2.225000E-01 |
| Classical-VS-Normal |
4.641000E-03 |
| Tall-VS-Follicular |
9.826800E-01 |
| Tall-VS-Other |
4.556600E-01 |
| Tall-VS-Normal |
6.395200E-03 |
| Follicular-VS-Other |
5.703400E-01 |
| Follicular-VS-Normal |
2.140900E-03 |
| Other-VS-Normal |
2.555900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.221160E-03 |
| Normal-vs-N1 |
1.995710E-04 |
| N0-vs-N1 |
2.003400E-01 |
|
|
